Recent advances in the development of an
โ
Bruce E. Ivins; Susan L. Welkos
๐
Article
๐
1988
๐
Springer
๐
English
โ 896 KB
Human anthrax vaccines currently licensed in the United States and Western Europe consist of alum-precipitated or aluminum hydroxide-adsorbed supernatant material from fermentor cultures of toxigenic, nonencapsulated strains of Bacillus anthracis. These vaccines have several drawbacks, including the